The cholecystokinin-A receptor mediates inhibition of food intake yet is not essential for the maintenance of body weight

Journal of Clinical Investigation

Volumn 103, Issue 3, 1999, Pages 383-391

  Kopin, Alan S ^a,d   Mathes, Wendy Foulds ^b   McBride, Edward W ^a   Nguyen, Minh ^a   Al Haider, Wisam ^a   Schmitz, Frank ^a   Bonner Weir, Susan ^c   Kanarek, Robin ^b   Beinborn, Martin ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS UNIVERSITY   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d Tupper Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ; CHOLECYSTOKININ A RECEPTOR; GASTRIN;

ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; FOOD INTAKE; GENE EXPRESSION; GENE TARGETING; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; KNOCKOUT MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; TASTE AVERSION;

EID: 0032905886     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI4901     Document Type: Article

References (66)

1. Gibbs, J., Young, R.C., and Smith, G.P. 1973. Cholecystokinin decreases food intake in rats. J. Comp. Physiol. Psychol. 84:488-95.
2. Himick, B.A., and Peter, R.E. 1994. CCK/gastrin-like immunoreactivity in brain and CCK suppression of feeding in goldfish. Am. J. Physiol. 267:R841-R851.
3. Khosla, S., and Crawley, J.N. 1988. Potency of L-364,718 as an antagonist of the behavioral effects of peripherally administered cholecystokinin. Life Sci. 42:153-159.
4. Hirosue, Y., et al. 1993. Cholecystokinin octapeptide analogues suppress food intake via central CCK-A receptors in mice. Am. J. Physiol. 265:R481-R486.
5. Asin, K.E., Bednarz, L., Nikkel, A.L., Gore, P.A., Jr., and Nadzan, A.M. 1992. A-71623, a selective CCK-A receptor agonist, suppresses food intake in the mouse, dog, and monkey. Pharmacol. Biochem. Behav. 42:699-704.
6. Baldwin, B.A. 1992, CCK as a putative satiety factor in farm animals. In Multiple cholecystokinin receptors in the CNS. C.T. Dourish, S.J. Cooper, S.D. Iversen, and L.L. Iversen, editors. Oxford University Press. New York, NY. 206-221.
7. Dourish, C.T. 1992. Behavioral analysis of the role of CCK-A and CCK-B receptors in the control of feeding in rodents. In Multiple Cholecystokinin receptors in the CNS. C.T. Dourish, S.J. Cooper, S.D. Iversen, and L.L. Iversen editors. Oxford University Press. New York, NY. 234-253.
8. Smith, G.P., and Gibbs, J. 1992. The development and proof of the CCK hypothesis of satiety. In Multiple cholecystokinin receptors in the CNS. C.T. Dourish, S.J. Cooper, S.D. Iversen, and L.L. Iversen, editors. Oxford University Press. New York, NY. 166-182.
9. Crawley, J.N., and Corwin, R.L. 1994. Biological actions of cholecystokinin. Peptides. 15:731-755.
10. Jensen, R.T., et al. 1994. Distinguishing multiple CCK receptor subtypes. Studies with guinea pig chief cells and transfected human CCK receptors. Ann. NY Acad. Sci. 713:88-106.
11. Hewson, G., Leighton, G.E., Hill, R.G., and Hughes, J. 1988. The cholecystokinin receptor antagonist L364,718 increases food in take in the rat by attenuation of the action of endogenous cholecystokinin. Br. J. Pharmacol. 93:79-84.
12. Reidelberger, R.D., and O'Rourke, M.F. 1989. Potent cholecystokinin antagonist L-364,718 stimulates food intake in rats. Am. J. Physiol. 257:R1512-R1518.
13. Moran, T.H., Ameglio, P.J., Peyton, H.J., Schwartz, G.J., and McHugh, P.R. 1993. Blockade of type A, but not type B, CCK receptors postpones satiety in rhesus monkeys. Am. J. Physiol. 265:R620-R624.
14. Wolkowitz, O.M., et al. 1990. Hunger in humans induced by MK-329, a specific peripheral-type cholecystokinin receptor antagonist. Biol. Psychiatry. 28:169-173.
15. Gregory, P.C., McFadyen, M., and Rayner, D.V. 1989. Duodenal infusion of fat, cholecystokinin secretion and satiety in the pig. Physiol. Behav. 45:1021-1024.
16. Cooper, S.J., Dourish, C.T., and Barber, D.J. 1990. Reversal of the anorectic effect of (+)-fenfluramine in the rat by the selective cholecystokinin receptor antagonist MK-329. Br. J. Pharmacol. 99:65-70.
17. Dourish, C.T., Rycroft, W., and Iversen, S.D. 1989. Postponement of satiety by blockade of brain cholecystokinin (CCK-B) receptors. Science. 245:1509-1511.
18. Reidelberger, R.D., Varga, G., and Solomon, T.E. 1991. Effects of selective cholecystokinin antagonists L364,718 and L365,260 on food intake in rats. Peptides. 12:1215-1221.
19. Corwin, R.L., Gibbs, J., and Smith, G. P. 1991. Increased food intake after type A but not type B cholecystokinin receptor blockade. Physiol. Behav. 50:255-258.
20. Weatherford, S.C., Chiruzzo, F.Y., and Laughton, W.B. 1992. Satiety induced by endogenous and exogenous cholecystokinin is mediated by CCK-A receptors in mice. Am. J. Physiol. 262:R574-R578.
21. Moran, T.H., Ameglio, P.J., Schwartz, G.J., and McHugh, P.R. 1992. Blockade of type A, not type B. CCK receptors attenuates satiety actions of exogenous and endogenous CCK. Am. J. Physiol. 262:R46-R50.
22. Susulic, V.S., et al. 1995. Targeted disruption of the beta 3-adrenergic receptor gene. J. Biol. Chem. 270:29483-29492.
23. Tecott, L.H., et al. 1995. Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors. Mature. 374:542-546.
24. Ohki-Hamazaki, H., et al. 1997. Mice lacking bombesin receptor subtype-3 develop metabolic defects and obesity. Nature. 390:165-169.
25. Huszar, D., et al. 1997. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell. 88:131-141.
26. Turton, M.D., et al. 1996. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature. 379:69-72.
27. Scrocchi, L.A., et al., 1996. Glucose in tolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene. Nat. Med. 2:1254-1258.
28. Erickson, J.C., Clegg, K.E., and Palmiter, R.D. 1996. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature. 381:415-421.
29. Funakoshi, A., et al. 1995. An animal model of congenital defect of gene expression of cholecystokinin (CCK)-A receptor. Biochem. Biophys. Res. Commun. 210:787-796.
30. Takiguchi, S., et al. 1997. Disrupted cholecystokinin type-A receptor (CCKAR) gene in OLETF rats. Gene. 197:169-175.
31. Kawano, K., et al. 1992. Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes. 41:1422-1428.
32. Takiguchi, S., et al. 1998. A disrupted cholecystokinin A receptor gene induces diabetes in obese rats synergistically with ODB1 gene. Am. J. Physiol. 274:E265-E270.
33. Langhans, N., et al. 1997. Abnormal gastric histology and decreased acid production in cholecystokinin-B/gastrin receptor-deficient mice. Gastroenterology. 112:280-286.
34. Nagata, A., et al. 1996. G protein-coupled cholecystokinin-B/gastrin receptors are responsible for physiological cell growth of the stomach mucosa in vivo. Proc. Natl. Acad. Sci. USA. 93:11825-11830.
35. de Weerth, A., Pisegna, J.R., Huppi, K., and Wank, S.A. 1993. Molecular cloning, functional expression and chromosomal localization of the human cholecystokinin type A receptor. Biochem. Biophys. Res. Commun. 194:811-818.
36. Ulrich, C.D., et al. 1993. Molecular cloning and functional expression of the human gallbladder cholecystokinin A receptor. Biochem. Biophys. Res. Commun. 193:204-211.
37. Lacourse, K.A., Lay, J.M., Swanberg, L.J., Jenkins, C., and Samuelson, L.C. 1997. Molecular structure of the mouse CCK-A receptor gene. Biochem. Biophys. Res. Commun. 236:630-635.
38. Takata, Y., Takiguchi, S., Funakoshi, A., and Kono, A. 1995. Gene structure of rat cholecystokinin type-A receptor. Biochem. Biophys. Res. Commun. 213:958-966.
39. Baldwin, J.M. 1993. The probable arrangement of the helices in G protein-coupled receptors. EMBO J. 12:1693-1703.
40. Nagy, A., Rossant, J., Nagy, R., Abramow-Newerly, W., and Roder, J.C. 1993. Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc. Natl. Acad. Sci. USA. 90:8424-8428.
41. Manjunath, N., Correa, M., Ardman, M., and Ardman, B. 1995. Negative regulation of T-cell adhesion and activation by CD43. Nature. 377:535-538.
42. Liddle, R.A. 1994. Cholecystokinin. In Gut pepttdes. J.H. Walsh and G.J. Dockray, editors. Raven Press. New York, NY. 175-216.
43. Bruning, J.C., et al. 1997. Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles. Cell. 88:561-572.
44. Ishida, K., Mizuno, A., Sano, T., Shi, K., and Shima, K. 1993. Plasma glucagon responses to insulin-induced hypoglycemia and arginine in spontaneous non-insulin-dependent diabetes mellitus (NIDDM) rats, Otsuka Long Evans Tokushima Fatty (OLETF) strain. Acta Endocrinol. 129:585-593.
45. Miyasaka, K., et al. 1994. Lack of satiety effect of cholecystokinin (CCK) in a new rat model not expressing the CCK-A receptor gene. Neurosci. Lett. 180:143-146.
46. Funakoshi, A., et al. 1996. Pancreacic endocrine dysfunction in racs not expressing the cholecystokinin-A receptor. Pancreas. 12:230-236.
47. Schmitz, F., et al 1996. CCK-A receptor deficient mice have increased susceptibility to cholesterol gallstones. Hepatol. 24:246A. (Abstr)
48. Kissileff, H.R., Pi-Sunyer, F.X., Thornton, J., and Smith, G.P. 1981. C-terminal octapeptide of cholecystokinin decreases food intake in man. Am. J. Clin. Nutr. 34:154-160.
49. Ervin, G.N., and Teeter, M.N. 1986. Cholecystokinin octapeptide and lithium produce different effects on feeding and taste aversion learning. Physiol. Behav. 36:507-512.
50. West, D.B., Greenwood, M.R., Marshall, K.A., and Woods, S.C. 1987. Lithium chloride, cholecystokinin and meal patterns: evidence that cholecystokinin suppresses meal size in rats without causing malaise. Appetite. 8:221-227.
51. Lieverse, R.J. Jansen, J.B., Masclee, A.M., and Lamers, C.B. 1994. Satiety effects of cholecystokinin in humans. Gastroenterology. 106:1451-1454.
52. Crawley, J.N., and Beinfeld, M.C. 1983. Rapid development of tolerance to the behavioural actions of cholecystokinin. Nature. 302:703-706.
53. West, D.B., Fey, D., and Woods, S.C. 1984. Cholecystokinin persistently suppresses meal size but not food intake in free-feeding rats. Am. J. Physsiol. 246:R776-R787.
54. Naggert, J., Harris, T., and North, M. 1997. The genetics of obesity. Curr. Opin. Genet. Dev. 7:398-404.
55. Rosenbaum, M., Leibel, R.L., and Hirsch, J. 1997. Obesity. N. Engl. J. Med. 337:396-407.
56. Nowak, M.A., Boerlijst, M.C., Cooke, J., and Smith, J.M. 1997. Evolution of genetic redundancy. Nature. 388:167-171.
57. Sakurai, T., et al. 1998. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell. 92:573-585.
58. Hampton, L. L., et al. 1998. Loss of bombesin-induced feeding suppression in gastrin-releasing peptide receptor-deficient mice. Proc. Natl. Acad. Sci. USA. 953:188-192.
59. Flier, J.S., and Maratos-Flier, E. 1998. Obesity and the hypothalamus: novel peptides for new pathways. Cell. 92:437-440.
60. Williams, J.A., Gryson, K.A., and McChesney, D.J. 1986. Brain CCK receptors: species differences in regional distribution and selectivity. Peptides. 7:293-296.
61. Sekiguchi, R., and Moroji, T. 1986. A comparative study on characterization and distribution of cholecystokinin binding sites among the rat, mouse and guinea pig brain. Brain Res. 399:271-281.
62. Hill, D.R., Shaw, T.M., and Woodruff, G.N. 1987. Species differences in the localization of 'peripheral' type cholecystokinin receptors in rodent brain. Neurosci. Lett. 79:286-289.
63. Miceli, M.O., and Steiner, M. 1989. Novel localizations of central- and peripheral-type cholecystokinin binding sites in Syrian hamster brain as determined by autoradiography. Eur. J. Pharmacol. 169:215-224.
64. Hill, D.R., and Woodruff, G.N. 1990. Differentiation of central cholecystokinin receptor binding sites using the non-peptide antagonists MK-329 and L-365,260. Brain Res. 526:276-283.
65. Reaven, E.P., and Reaven, G.M. 1981. Structure and function changes in the endocrine pancreas of aging rats with reference to the modulating effects of exercise and caloric restriction. J. Clin. Invest. 68:75-84.
66. Wank, S. A., et al. 1992. Purification, molecular cloning, and functional expression of the cholecystokinin receptor from rat pancreas. Proc. Natl. Acad. Sci. USA. 89:3125-3129.